Utilising NITs in MASLD

Update: 2025-11-15

Description

Join Prof Emmanuel Tsochatzis as we discuss on interpreting and utilising NITs in assessing MASLD.

Detecting at-risk steatotic liver disease and liver fibrosis in the community: https://journals.lww.com/hep/fulltext/9900/detecting_at_risk_steatotic_liver_disease_and.1285.aspx

Comments

In Channel

How to manage HPS?

2025-12-2607:57

Who should I refer for SIRT?

2025-12-1309:21

How to use a MASLD Pathway

2025-11-2906:13

Utilising NITs in MASLD

2025-11-1505:31

Second line treatment for PBC: Selecting the right treatment

2025-11-0206:47

Second line therapy for PBC: Identifying the right patient

2025-10-0704:52

When should I stop Hepatitis B medication?

2025-09-1508:41

How do I treat Hep C when it isn't easy?

2025-09-0206:06

Coiling the Crisis: When Should EUS Step In for Gastric Varices?

2025-08-1108:47

When should I prescribe home terlipressin?

2025-07-2607:09

Surveillance in PSC

2025-07-1506:21

Diagnosing and managing cholangiocarcinoma in PSC

2025-01-1209:17

How to diagnose HPS

2024-07-1107:51

How to interpret HVPG measurement

2024-03-2108:43

Managing COVID in patients with cirrhosis

2022-07-1309:51

Managing alcohol use disorder

2022-07-0906:18

When should I start longterm albumin?

2025-08-0107:13

Early Liver Transplantation in Alcohol associated hepatitis

2024-09-1608:03

Managing malnutrition in liver disease

2024-06-2208:02

When should I refer for SBRT?

2024-05-2507:12

00:00

1.0x

#box-pro-ellipsis-176696849611794{-webkit-line-clamp:2;}Utilising NITs in MASLD

Utilising NITs in MASLD

Rohit Gupta

Utilising NITs in MASLD